Sex/Gender Medicine - The Biological Basis for Personalized Care in Cardiovascular Medicine

被引:63
作者
Arain, Faisal A. [2 ]
Kuniyoshi, Fatima H. [2 ]
Abdalrhim, Ahmed D. [2 ]
Miller, Virginia M. [1 ,3 ]
机构
[1] Mayo Clin, Coll Med, Dept Surg, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Gen Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Atherosclerosis; Autonomic nervous system; Heart failure; Hypertension; ESTROGEN-RECEPTOR-ALPHA; CORONARY-ARTERY CALCIUM; C-REACTIVE PROTEIN; TYROSINE-HYDROXYLASE EXPRESSION; HORMONE REPLACEMENT THERAPY; ACUTE MYOCARDIAL-INFARCTION; SEX-BASED DIFFERENCES; GENDER-DIFFERENCES; BLOOD-PRESSURE; RISK-FACTORS;
D O I
10.1253/circj.CJ-09-0588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sex differences in morbidity and mortality associated with cardiovascular disease have been recognized by the medical community for decades. Investigation into the underlying biological basis of these differences was largely neglected by the scientific community until a report released by the Institute of Medicine in the United States in 2001 "Exploring the Biological Contributions to Human Health: Does Sex Matter?" Recommendations from this report included the need for more accurate use of the terms "sex" and "gender", better tools and resources to study the biological basis of sex differences, integration of findings from different levels of biological organization and continued synergy between basic and clinical researchers. Ten years after the Institute's report, this review evaluates some of the sex differences in cardiovascular disease, reviews new approaches to study sex differences and emphasizes areas where further research is required. In the era of personalized medicine, the study of the biological basis of sex differences promises to optimize preventive, diagnostic: and therapeutic strategies for cardiovascular disease in men and women, but will require diligence by the scientific and medical communities to remember that sex does matter. (Circ J 2009; 73: 1774-1782)
引用
收藏
页码:1774 / 1782
页数:9
相关论文
共 135 条
  • [51] Sex differences in the effectiveness of statins after myocardial infarction
    Karp, Igor
    Chen, Shun-Fu
    Pilote, Louise
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (03) : 333 - 338
  • [52] Impact of metabolic syndrome on coronary plaque vulnerability in Japanese women with acute coronary syndrome
    Kato, Masaya
    Dote, Keigo
    Sasaki, Shota
    Ueda, Kentaro
    Nakano, Yoshinori
    Naganuma, Toru
    Watanabe, Yoshikazu
    Yokoyama, Haruko
    [J]. CIRCULATION JOURNAL, 2008, 72 (06) : 940 - 945
  • [53] Estrogen signaling in the hypothalamus
    Kelly, MJ
    Qiu, J
    Ronnekleiv, OK
    [J]. VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 71, 2005, 71 : 123 - 145
  • [54] Sex differences in outcomes after cardiac catheterization - Effect modification by treatment strategy and time
    King, KM
    Ghali, WA
    Faris, PD
    Curtis, MJ
    Galbraith, PD
    Graham, MM
    Knudtson, ML
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (10): : 1220 - 1225
  • [55] Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria
    Kobayashi, Junji
    Nishimura, Kouji
    Matoba, Munetoshi
    Maekawa, Nobumasa
    Mabuchi, Hiroshi
    [J]. CIRCULATION JOURNAL, 2007, 71 (11) : 1734 - 1737
  • [56] Koledova Vera V, 2007, Expert Rev Cardiovasc Ther, V5, P777
  • [57] Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on framingham risk score
    Lakoski, Susan G.
    Greenland, Philip
    Wong, Nathan D.
    Schreiner, Pamela J.
    Herrington, David M.
    Kronmal, Richard A.
    Liu, Kiang
    Blumenthal, Roger S.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (22) : 2437 - 2442
  • [58] Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD
    Lakoski, Susan G.
    Cushman, Mary
    Blumenthal, Roger S.
    Kronmal, Richard
    Arnett, Donna
    D'Agostino, Ralph B., Jr.
    Detrano, Robert C.
    Herrington, David M.
    [J]. ATHEROSCLEROSIS, 2007, 193 (02) : 401 - 407
  • [59] Ling Shanhong, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P29
  • [60] Androgens and cardiovascular disease
    Liu, PY
    Death, AK
    Handelsman, DJ
    [J]. ENDOCRINE REVIEWS, 2003, 24 (03) : 313 - 340